pepmg_

Study summary · research use only

Does kisspeptin exert a local modulatory effect on bovine ovarian steroidogenesis?

Study · Reproduction & fertility · 2023 · DOI 10.1530/RAF-22-0088 · PMID 36745024

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This study examined whether kisspeptin modulates bovine ovarian steroidogenesis, using granulosa (GC) and theca interna (TC) cells from antral follicles of 3-18 mm across five size classes, and corpora lutea (CL) at early, mid, and regressing stages, analyzed by RT-qPCR, plus cultured GC and TC treated for 4 days with kisspeptin-10 or a kisspeptin antagonist (p234), each at 10-10-10-6M, alone or with FSH, LH, or forskolin. KISS1 and KISS1R transcripts were detected in TC, GC, and CL, with differences between follicle categories and CL stages. Steroid secretion (measured by ELISA) and viable cell number (neutral red uptake) were unaffected by kisspeptin-10 or the antagonist in any of the four culture models, and the authors state this does not support a direct intra-ovarian role for kisspeptin in steroidogenesis or cell proliferation/survival.

Abstract

Kisspeptin, a hypothalamic neuropeptide encoded by the KISS1 gene, has a pivotal role in promoting GnRH secretion in mammals. Kisspeptin and its receptor (KISS1R) are also expressed in certain peripheral tissues including gonads, suggesting intra-gonadal roles. Such actions at the level of the bovine ovary have not been explored previously. The current aims were to determine whether KISS1 and its receptor (KISS1R) are expressed in the bovine ovary and whether kisspeptin or a kisspeptin antagonist can modulate ovarian steroid production by cultured ovarian cells. Granulosa (GC) and theca interna (TC) were collected from antral follicles (3-18 mm) categorized into five class sizes. Early, mid and regressing corpora lutea (CL) were also collected for RT-qPCR analysis of KISS1 and KISS1R expression. Bovine TC and GC cultured under both non-luteinizing (serum-free) and luteinizing (serum-supplemented) conditions were treated for 4 days with kisspeptin-10 (10-10-10-6M) or kisspeptin antagonist (p234; 10-10-10-6M), alone and in combination with either FSH (GC), LH (TC) or forskolin (luteinized GC/TC). Steroid secretion (GC: oestradiol, progesterone; TC: androstenedione, progesterone; luteinized GC/TC: progesterone) was measured by ELISA and viable cell number determined by neutral red uptake assay. KISS1 and KISS1R transcripts were detected in TC, GC and CL with significant differences between follicle categories and CL stages. However, neither kisspeptin-10 nor kisspeptin antagonist affected steroid secretion or viable cell number in any of the four ovarian cell culture models. As such, the hypothesis that kisspeptin has a direct intra-ovarian role to modulate follicular or luteal steroidogenesis, or cell proliferation/survival, is not supported.

Read the full study on PubMed ↗ Open-access full text ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.